FDA Orange Book
Generic for Eucrisa
Eucrisa contains crisaborole. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Eucrisa is crisaborole. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Eucrisa and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Eucrisa products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| ointment, topical | 2% | Marketed (Rx) | AB | 1 | AB |
NDA 207695, held by ANACOR PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic crisaborole
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| MACLEODS PHARMACEUTICALS LTD | 216242 | AB (A-rated, therapeutically equivalent) | September 24, 2026 | 2% |
Eucrisa patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8501712 | February 16, 2027 | Method of use | U-1932 | 207695 |
| 9682092 | February 16, 2027 | Method of use | U-1932 | 207695 |
| 8501712*PED | August 16, 2027 | Method of use | None | 207695 |
| 9682092*PED | August 16, 2027 | Method of use | None | 207695 |
| 8039451 | June 29, 2029 | Drug substance, Drug product | None | 207695 |
| 8039451*PED | December 29, 2029 | Method of use | None | 207695 |
| 8168614 | January 20, 2030 | Method of use | U-1932 | 207695 |
| 8168614*PED | July 20, 2030 | Method of use | None | 207695 |
Eucrisa exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| D-191 | New dosing schedule | April 3, 2026 | 207695 |
Eucrisa NDC codes
Questions
Is there a generic for Eucrisa?
Yes. The generic name for Eucrisa is crisaborole. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Eucrisa?
The active ingredient in Eucrisa is crisaborole, per the FDA Orange Book.
When does the Eucrisa patent expire?
The last patent listed for Eucrisa in the Orange Book expires July 20, 2030. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.